Detalhe da pesquisa
1.
Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL).
Br J Haematol
; 204(2): 389-390, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964473
2.
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity After Supportive Stem Cell Boost in Multiple Myeloma.
Acta Haematol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447541
3.
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia.
Hematol Oncol
; 38(1): 74-81, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755141
4.
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
Hematol Oncol
; 35(4): 789-796, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27301773
5.
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.
J Clin Med
; 12(6)2023 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983378
6.
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.
Cells
; 11(17)2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36078155
7.
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.
Cancers (Basel)
; 13(13)2021 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34202404
8.
Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center.
Bone Marrow Transplant
; 57(6): 1010-1012, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383289
9.
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
Leuk Res
; 53: 28-34, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27978458